Company snapshot
Market Cap
$2B
Mid-cap2016 — today
10-Year Price
-58%
2016 — today
52-Week Range
$16.97$29.55
Current $29.18· 97%
Featured in rankings
Most Undervalued Healthcare StocksBest Healthcare GARP StocksMost Undervalued Value StocksMost Undervalued Growth StocksBest GARP Stocks (Growth at a Reasonable Price)GARP Universe
Rankings recomputed after each US market close — see where MD stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| ALNYAlnylam Pharmaceuticals, Inc. | 8.8 | — |
| ZTSZoetis Inc. | 13.0 | 2.7% |
| CNCCentene Corporation | 23.5 | — |
| ALCAlcon Inc. | 54.7 | 0.5% |
| RVMDRevolution Medicines, Inc. | -21.5 | — |
| ONCBeOne Medicines Ltd. | 5.1 | — |
| IDXXIDEXX Laboratories, Inc. | 40.8 | — |
| TEVATeva Pharmaceutical Industries Limited | 69.1 | — |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
15.9
Historically pricey
Historically pricey — last 10 years
Sector median 25.4below sector
P/B ratio
2.7
Near historic high
Near historic highs — last 10 years
Sector median 2.2above sector
EV / EBITDA
10.5
Below average
Below the 10-year average
Sector median 15.7below sector
PEG ratio
0.3
Near historic low
Near historic low — last 10 years
Sector median 1.8below sector
FCF Yield
9.0%
Below average
Below the 10-year average
Sector median -12.6%above sector